Pharscin Pharma(SZ:002907) Zheng Quan Zhi Xing·2025-05-13 13:25Core Viewpoint - The announcement details the share reduction plan by the controlling shareholder Chengdu Local Construction Machinery Engineering Co., Ltd. and senior management personnel, indicating their intention to sell a total of up to 12,527,889 shares, which is approximately 3% of the company's total share capital, over a specified period [1][3][9] Shareholder Information - Chengdu Local Construction Machinery Engineering Co., Ltd. holds 175,572,175 shares, accounting for 42.04% of the company's total share capital [1] - Senior management personnel, specifically Ms. Peng Xiaoyan, holds 17,500 shares, representing 0.0042% of the total share capital [1] Share Reduction Plan Details - Chengdu Local Construction plans to reduce its holdings by up to 4,175,963 shares (1% of total shares) through centralized bidding and up to 8,351,926 shares (2% of total shares) through block trading, totaling a maximum of 12,527,889 shares [1][3] - Ms. Peng Xiaoyan intends to reduce her holdings by no more than 4,375 shares, which is less than 0.01% of the total share capital [2][3] Reduction Timing and Method - The reduction period is set from June 6, 2025, to September 5, 2025, starting 15 trading days after the announcement [1][3] - The reduction will be executed through centralized bidding and block trading, with the price determined by market conditions [2][5] Compliance and Commitments - Chengdu Local Construction has committed to adhere to relevant regulations regarding share reduction and has previously complied with lock-up commitments [6][7][8] - Ms. Peng Xiaoyan has also followed the regulations regarding share transfer during her tenure and after leaving the company [8] Risk and Impact Assessment - The company emphasizes that the share reduction plan will not lead to a change in control or significantly impact the company's governance structure or ongoing operations [9]